Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

The Eda gene helps regulate the hair cycle in goats.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The combination of encorafenib and binimetinib caused few skin issues.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Extracts from Tridax procumbens L. have strong anti-inflammatory and antioxidant effects and block inflammation-causing enzymes.

RTA 408 cream protects mice from radiation skin damage.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Tribulus terrestris may protect the liver from drug damage.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

JAK inhibitors are effective treatments for alopecia areata.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Some prostate cancers have gene changes that may affect treatment with certain drugs.